Last summer Intellia released the first data showing that CRISPR could be used in the body to combat a disease. Now, after publishing the data in NEJM, what are the next steps? The company’s CEO joins STAT at a Feb. 24 event to lay them out and answer your questions. Sign up here.
‘Good, not great’: Some long Covid patients see their symptoms improve, but full recovery is elusive
By Elizabeth cooney
Joni White in her glass studio in her Hillsborough, N.C., home. (Lissa Gotwals for STAT)
How long does long Covid last? And what does it mean to achieve full recovery? If you ask Hillsborough, N.C., glass artist Joni White, she’ll tell you she just wants to feel like herself again — or something close to it. And she’s almost there.
ASGCT’s 25th Annual Meeting keynote speakers include gene therapy pioneers and former NIH director
Three highly distinguished gene and cell therapy leaders have been selected to give keynote presentations during this year’s Annual Meeting, May 16-19, which will be held virtually and in Washington, D.C. The field-leading plenary session speakers include Drew Weissman, MD, PhD; Francis Collins, MD, PhD; and Kathy High, MD. Preview the program agenda for details. Register now, save $100.
No comments